News

Press Releases

Neurona Therapeutics Raises $41.5M to Advance Neural Network-Rebalancing Cell Therapies for the Treatment of Epilepsy and other Neurological Disorders

June 22, 2021

Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI
June 16, 2021

Neurona Therapeutics Presents Preclinical Data from Lead Inhibitory Cell Therapy Program, Demonstrating Significant Seizure Suppression in Model of Focal Epilepsy
April 19, 2021

Neurona Therapeutics awarded a $4.8M translational grant from CIRM to advance epilepsy program to the pre-IND stage
October 31, 2019

CIRM Discovery Quest Award program: Neurona Therapeutics receives funding
December 14, 2017 

Neurona Therapeutics Launches with $23.5 Million in Series A Funding to Repair Damaged Neural Circuits
December 1, 2015

 

In the news

 

Neurona Therapeutics is dashing to the clinic with its cell therapy for epilepsy — but first, another venture round
June 23, 2021

Transplanting Specialized Neurons Cory R Nicholas, PhD, Co-Founder and CEO of Neurona Therapeutics, talks to Pharmafile about the world of neurological disorders and transplantation. (This article is taken from Pharmafile Spring 2021, pages 54-55. © Samedan Ltd)
May 19, 2021

Human Neuron Transplants Treat Spinal Cord Injury in Mice
September 22, 2016 

The Daily Startup: How This VC Firm is Building Its Own Biotech Companies
May 4, 2015


Stem cells to transplant in the brain: Stealth UCSF spinout Neurona Therapeutics raises $7.6M

December 24, 2014


Successful transplantation of lab-derived interneurons in mice

May 07, 2013


Epileptic mice cured with transplantation of MGE interneurons

May 07, 2013


Reining in pain

June 21, 2012


Progenitor cell therapy for epilepsy

September 10, 2009